Prevalence of depressive symptoms and correlates among individuals who self-reported Sars-CoV-2 infection after optimizing the Covid-19 response in China
Dados Bibliográficos
Background: The burden of depression symptoms has increased among individuals infected with SARS-CoV-2 during COVID-19 pandemic. However, the prevalence and associated factors of depressive symptoms among individuals infected with SARS-CoV-2 remain uncertain after optimizing the COVID-19 response in China. Methods: An online cross-sectional survey was conducted among the public from January 6 to 30, 2023, using a convenience sampling method. Sociodemographic and COVID-19 pandemic-related factors were collected. The depression symptoms were assessed using the Patient Health Questionnaire-9 (PHQ-9). Logistic regression analysis was performed to explore the associated factors with depressive symptoms. Results: A total of 2,726 participants completed the survey. The prevalence of depression symptoms was 35.3%. About 58% of the participants reported experiencing insufficient drug supply. More than 40% of participants reported that they had missed healthcare appointments or delayed treatment. One-third of participants responded experiencing a shortage of healthcare staff and a long waiting time during medical treatment. Logistic regression analysis revealed several factors that were associated with depression symptoms, including sleep difficulties (OR, 2.84; 95% CI, 2.34-3.44), chronic diseases (OR, 2.15; 95% CI, 1.64-2.82), inpatient treatment for COVID-19 (OR, 3.24; 95% CI, 2.19-4.77), with COVID-19 symptoms more than 13 days (OR, 1.30, 95% CI 1.04-1.63), re-infection with SARS-CoV-2 (OR, 1.52; 95% CI, 1.07-2.15), and the increased in demand for healthcare services (OR, 1.32; 95% CI, 1.08-1.61). Conclusion: This study reveals a moderate prevalence of depression symptoms among individuals infected with SARS-CoV-2. The findings underscore the importance of continued focus on depressive symptoms among vulnerable individuals, including those with sleeping difficulties, chronic diseases, and inpatient treatment for COVID-19. It is necessary to provide mental health services and psychological interventions for these vulnerable groups during the COVID-19 epidemic
2019-20 coronavirus outbreak · Anxiety · Betacoronavirus · China · Depressive symptoms · Disease · Geography · Outbreak · Psychiatry · Sars virus · Severity of illness · COVID-19 and Mental Health · Long-Term Effects of COVID-19 · Medicine · Pharmacological Receptor Mechanisms and Effects · Internal Medicine · Virology
Prevalence of mental health problems during the Covid-19 pandemic
The differential psychological distress of populations affected by the Covid-19 pandemic
Mental health and well-being during the Covid-19 pandemic
Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic
Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression
Trajectories of anxiety and depressive symptoms during enforced isolation due to Covid-19 in England
Covid-19 and mental health in Brazil
The Role of Sleep in Emotional Brain Function
Month neurological and psychiatric outcomes in 236 379 survivors of Covid-19
Prevalence of Mental Health Problems During Virus Epidemics in the General Public, Health Care Workers and Survivors
Anxiety, depression, and insomnia among nurses during the full liberalization of Covid-19
Prevalence and associated factors of depression and anxiety symptoms among college students
Risk factors for poor outcomes in hospitalised Covid-19 patients
Prevalence of depression, anxiety, and stress among first responders for medical emergencies during Covid-19 pandemic
Psychological responses and lifestyle changes among pregnant women with respect to the early stages of Covid-19 pandemic
Association between quarantine and sleep disturbance in Hong Kong adults
The effect of resource loss on depression and peritraumatic distress during the early period of the Covid-19
| Velocidade de citação | historical |
|---|---|
| Altamente citado | Não |